Donepezil
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Stroke
Conditions
Stroke, Aphasia
Trial Timeline
Feb 1, 2003 → Mar 1, 2005
NCT ID
NCT00196690About Donepezil
Donepezil is a approved stage product being developed by Pfizer for Stroke. The current trial status is completed. This product is registered under clinical trial identifier NCT00196690. Target conditions include Stroke, Aphasia.
What happened to similar drugs?
6 of 20 similar drugs in Stroke were approved
Approved (6) Terminated (6) Active (10)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00174382 | Phase 3 | Terminated |
| NCT00182845 | Approved | Completed |
| NCT00196690 | Approved | Completed |
Competing Products
20 competing products in Stroke